Pictet Asset Management
TYRA icon

Pictet Asset Management’s Tyra Biosciences TYRA Stock Holding History

Pictet Asset Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-459,113
Closed -$4.27M – 2055
2025
Q1 		$4.27M Buy
459,113
+105,101
+30% +$1.36M ﹤0.01% 823
2024
Q4 		$4.92M Buy
+354,012
New +$6.42M 0.01% 818

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Pictet Asset Management's TYRA Position: Q2 2025 in Review

Pictet Asset Management sold out of Tyra Biosciences (TYRA) in Q2 2025, closing a stake of 459,113 shares — an estimated $4.27M sold.

Pictet Asset Management first reported a position in TYRA in Q4 2024 and held it in 2 quarters. The position peaked at $4.92M in Q4 2024. 121 funds tracked by Wall St. Rank hold TYRA as of Q2 2025.

  • Pictet Asset Management reported no remaining Tyra Biosciences position as of Q2 2025 after selling out during the quarter.
  • Pictet Asset Management sold 459,113 Tyra Biosciences shares in Q2 2025, an estimated $4.27M.
  • Pictet Asset Management first reported a position in Tyra Biosciences in Q4 2024 and held it in 2 quarters.
  • Pictet Asset Management's Tyra Biosciences position peaked at $4.92M in Q4 2024.
  • 121 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2025.

Based on Pictet Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.